Therapeutic Plasma Exchange in Neuromyelitis Optica Spectrum Disorder: Real-World Clinical Outcomes and Safety From a Tertiary Care Center in Northwest India.
Aug 2026· Therapeutic apheresis and dialysis· 0 citations· 23 references
Medicine
TL;DR
Therapeutic Plasma Exchange is a safe and effective rescue therapy for steroid-refractory NMOSD exacerbations, producing substantial neurological and visual recovery with a favorable safety profile.
Abstract
Background
AND
Objectives
Neuromyelitis Optica Spectrum Disorder (NMOSD) is a severe autoimmune demyelinating disorder of the central nervous system characterized by relapsing attacks that can result in permanent neurological disability. Therapeutic Plasma Exchange (TPE) is recommended for steroid-refractory acute exacerbations. This study evaluated the efficacy and safety of TPE in patients with acute NMOSD attacks.
Materials And Methods
A prospective observational study was conducted over 18 months at SMS Jaipur, India. Forty adult patients fulfilling the 2015 International Panel for NMO Diagnosis criteria and presenting with steroid-refractory acute attacks were enrolled. TPE was performed using continuous-flow centrifugation, exchanging 1.0-1.4 estimated plasma volumes per session for 3-7 alternate-day procedures. Clinical outcomes were assessed using the EDSS, Snellen visual acuity, and MRC muscle strength grading.
Results
The cohort had a female predominance (65.0%) with a mean age of 36.5 years. Acute first presentations accounted for 77.5% of cases, while 22.5% were relapses. Anti-aquaporin-4 antibody positivity was detected in 45.0% of patients. Among 37 patients with motor deficits, 94.6% showed clinical improvement following TPE, including marked (35.1%), moderate (43.2%), and mild (16.2%) responses. Mean EDSS improved significantly from 7.4 to 4.1 (95% CI and p < 0.001). Visual improvement was observed in 84.4% of patients with baseline visual impairment. Adverse events occurred in 25.0% of patients, predominantly transient hypotension and mild citrate-related hypocalcemia, with no procedure-related treatment discontinuation.
Conclusion
TPE is a safe and effective rescue therapy for steroid-refractory NMOSD exacerbations, producing substantial neurological and visual recovery with a favorable safety profile.
Neuromyelitis optica spectrum disorder (NMOSD) is a neuroimmunological astrocytopathy mediated by anti-aquaporin-4 (AQP4-IgG) antibodies that trigger complement-dependent cytotoxicity and activation of the terminal complement cascade in the central nervous system. Ravulizumab, a long-acting terminal complement C5 i...
T. Santibáñez, J. M. Valdés, C. Romero et al.· Frontiers in Immunology· 0 citations
Background Complement activation plays a key role in the pathogenesis of neuromyelitis optica spectrum disorder (NMOSD). While eculizumab effectively prevents relapses, its role in acute attacks remains uncertain. Methods We retrospectively analyzed 38 patients with acute NMOSD treated with eculizumab across seven tert...
Tao Wu, De-Cai Tian, De-Hui Huang et al.· Frontiers in Immunology· 0 citations
Neuromyelitis optica spectrum disorder (NMOSD) is a B-cell–mediated autoimmune disease associated with aquaporin-4 (AQP4-IgG) antibodies in which patients may require anticoagulation, including heparin for venous thromboembolism prophylaxis, thereby exposing them to a risk of heparin-induced thrombocytopenia (HIT), an...
A. Podlecka-Piętowska, Joanna Rychter, Kinga Sujkowska et al.· Frontiers in Immunology· 1 citation
Age at diagnosis may represent a relevant clinical factor when evaluating disability burden in NMOSD and further prospective multicenter studies are warranted to better define longitudinal outcomes and prognostic factors in LO-NMOSD.
O. Mirmosayyeb, Mehra Fekri, Mohammad Yazdan Panah et al.· Acta Neurologica Belgica· 0 citations
BACKGROUND
Guillain-Barré syndrome (GBS) is an acute immune-mediated peripheral neuropathy for which therapeutic apheresis is an established treatment option. Various treatment modalities, including double filtration plasmapheresis (DFPP), are widely used in clinical practice; however, real-world data on their clinical...
Jing-Wen Li, Ying Chen, Jun Wu et al.· Therapeutic apheresis and di...· 0 citations
Four clinical cases of NMOSD that illustrate the difficulties in making a timely diagnosis due to an ambiguous clinical, radiological and laboratory picture were presented and strategies to improve the early diagnosis of NMOSD to prevent such outcomes were proposed.
K. Bakhtiyarova, O. V. Lyutov, T. R. Galiullin et al.· Neurology, neuropsychiatry,...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.